9637 — Alebund Pharmaceuticals (Jiangsu) Share Price
Last trade - 00:00- HK$6.09bn
- HK$5.13bn
- CNY30.56m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 3.69 | ||
| Price to Tang. Book | 3.71 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 42.35 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -30.58% | ||
| Return on Equity | -99.93% | ||
| Operating Margin | -503.67% | ||
Financial Summary
| Year End 31st Dec | Unit | 2021 | 2022 | 2023 | 2024 | 2025 | 2026E | 2027E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CNYm | n/a | n/a | n/a | 6.53 | 30.56 | 153.63 | 167.04 | 368.29% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Alebund Pharmaceuticals (Jiangsu) Ltd is a China-based company principally engaged in biopharmaceutical business. The Company’s product portfolio in clinical and preclinical stages consists of one core product AP301 and other product candidates, including one late-clinical-stage product candidate AP306, one early-clinical-stage product candidate (AP303), and four preclinical product candidates (AP308, AP304, AP305, and AP307). The Company mainly operates its businesses in the domestic market and overseas markets.
Directors
- Last Annual
- December 31st, 2025
- Last Interim
- June 30th, 2026
- Incorporated
- May 20th, 2021
- Public Since
- June 29th, 2026
- No. of Employees
- 169
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Stock Exchange of Hong Kong Limited
- Shares in Issue
- 348,365,531
- Address
- YANGZHOU, 225100
- Web
- https://www.alebund.com
- Phone
- +86 2160836212
- Auditors
- Ernst & Young
Latest News for 9637
Upcoming Events for 9637
Similar to 9637
160 Health International
Stock Exchange of Hong Kong Limited
3D Medicines
Stock Exchange of Hong Kong Limited
3SBio
Stock Exchange of Hong Kong Limited
Ab&B Bio Tech JS
Stock Exchange of Hong Kong Limited
AIM Vaccine
Stock Exchange of Hong Kong Limited
FAQ
As of Today at 01:10 UTC, shares in Alebund Pharmaceuticals (Jiangsu) are trading at HK$17.48. This share price information is delayed by 15 minutes.
Shares in Alebund Pharmaceuticals (Jiangsu) last closed at HK$17.48 and the price had moved by over the past 365 days. In terms of relative price strength the Alebund Pharmaceuticals (Jiangsu) share price has matched the FTSE Developed Asia Pacific Index by over the past year.
The overall consensus recommendation for Alebund Pharmaceuticals (Jiangsu) is Strong Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreAlebund Pharmaceuticals (Jiangsu) does not currently pay a dividend.
Alebund Pharmaceuticals (Jiangsu) does not currently pay a dividend.
Alebund Pharmaceuticals (Jiangsu) does not currently pay a dividend.
To buy shares in Alebund Pharmaceuticals (Jiangsu) you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of HK$17.48, shares in Alebund Pharmaceuticals (Jiangsu) had a market capitalisation of HK$6.09bn.
Here are the trading details for Alebund Pharmaceuticals (Jiangsu):
- Country of listing: Hong Kong
- Exchange: HKG
- Ticker Symbol: 9637
Based on an overall assessment of its quality, value and momentum Alebund Pharmaceuticals (Jiangsu) is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Alebund Pharmaceuticals (Jiangsu) is HK$48.45. That is 177.16% above the last closing price of HK$17.48.
Analysts covering Alebund Pharmaceuticals (Jiangsu) currently have a consensus Earnings Per Share (EPS) forecast of -CNY1.50 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Alebund Pharmaceuticals (Jiangsu). Over the past six months, its share price has matched the FTSE Developed Asia Pacific Index by .
As of the last closing price of HK$17.48, shares in Alebund Pharmaceuticals (Jiangsu) were trading -39.48% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Alebund Pharmaceuticals (Jiangsu) PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at HK$17.48.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Alebund Pharmaceuticals (Jiangsu)'s directors